CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma
about
Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and ChemoresistanceCtBP2 overexpression promotes tumor cell proliferation and invasion in gastric cancer and is associated with poor prognosis.Down-regulation of the zinc-finger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesisBCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma.CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β - dependent manner in hepatocellular carcinoma.A genome wide association study of fast beta EEG in families of European ancestry.RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.In vitro three dimensional culture of hepatocellular carcinoma to measure prognosis and responsiveness to chemotherapeutic agents.EDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling.LncRNA NEAT1 Regulates Cell Viability and Invasion in Esophageal Squamous Cell Carcinoma through the miR-129/CTBP2 Axis.MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma.Assembly of human C-terminal Binding Protein (CtBP) into tetramers.PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
P2860
Q26775006-0F817EAC-02B8-4C43-B131-1EEAE7EE7575Q33709869-0CAE25A3-6F60-4FEB-BAA5-BA4B509D7547Q36905743-C8E2A261-A328-413B-83DF-B1723777FAFCQ37288407-9E222F8A-7F01-4067-84D3-8DFB545D4FC5Q38680645-C5FC5422-A01B-4FA7-AFE5-9D521AADAE08Q38706570-3409083B-1160-470E-884E-64AFB1285360Q39046526-E43AC01A-0652-4918-910E-D2E9562E0DACQ40517753-7096CA04-589A-407A-9287-8AB90EA1570DQ41828504-29C2BBD6-FCC6-48D7-A917-7132B35F06CAQ42371617-1ABC59FA-DA6C-4D96-8E47-72CA36D58316Q46357485-7286743F-4FAB-4E48-BC28-41D2E660A15CQ50499376-4A23F870-A3EC-4C47-8AF4-9B880D9C3F7BQ52560313-161BB92D-A6E2-482C-BA4E-151928D7F594Q55716702-994D38A2-17D6-49D3-9D67-FCEB694A0231
P2860
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
CtBP2 is an independent progno ...... on in hepatocellular carcinoma
@ast
CtBP2 is an independent progno ...... on in hepatocellular carcinoma
@en
type
label
CtBP2 is an independent progno ...... on in hepatocellular carcinoma
@ast
CtBP2 is an independent progno ...... on in hepatocellular carcinoma
@en
prefLabel
CtBP2 is an independent progno ...... on in hepatocellular carcinoma
@ast
CtBP2 is an independent progno ...... on in hepatocellular carcinoma
@en
P2093
P2860
P356
P1433
P1476
CtBP2 is an independent progno ...... on in hepatocellular carcinoma
@en
P2093
Changwei Dou
Qingguang Liu
P2860
P304
P356
10.18632/ONCOTARGET.2915
P407
P577
2015-02-01T00:00:00Z